Soliqua 100/33 Available for Adults with Type 2 Diabetes. Da Hee Han, PharmD | January 4, 2017 . Sanofi announced the launch of Soliqua 100/33 (insulin glargine and lixisenatide injection) for ...

The Wholesale Acquisition Cost (WAC) price of Soliqua 100/33 is $127 for a 300 Unit pen, which equals $19.90 per day at the average final dose of 47 Units used in the labeled clinical trial.

Years ago, Sanofi's Soliqua hit the diabetes market with the promise of combining an insulin and a GLP-1 medicine in a convenient once-daily treatment option for Type 2 diabetes. So far, though ...

In December 2016, Zealand received the $ 25 million milestone payment triggered by the FDA approval of Soliqua 100/33 Copenhagen, 4 January 2017 - Zealand Pharma (Zealand) reports that Sanofi ...